Search results for CONTACT COLASHIP.SHOP TO

Results found

Displaying items 1131 - 1140 of 1536 in total

• Export opportunity NOP-2025-01 - NOP for Canoe Procurement

  NOTICE OF PARTICIPATION NOP-2025-01 – Canoe Procurement Group of Canada (formerly RMA Trade) Buying GroupIssued: January 3, 2025The Canadian Free Trade Agreeme…

• Export opportunity 24006 - Branding Including Supply and Installation

  GENERAL INSTRUCTIONS TO VENDORSThe District School Board of Niagara (hereafter referred to as the DSBN) hereby invites submissions to pre-qualify Vendors of Re…

• Export opportunity Drugs

  Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient Certolizumab pegol (L…

• Export opportunity Drugs

  Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient mepolizumab (R03DX09)…

• Export opportunity Drugs

  Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient formoterol and aclidi…

• Export opportunity Drugs

  Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient Urapidil (C02CA06) wi…

• Export opportunity Drugs

  Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient Secukinumab (L04AC10)…

• Export opportunity Drugs

  Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient ranolazine (C01EB18) …

• Export opportunity Drugs

  Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient iron(III)-derisomalto…

• Export opportunity Drugs

  Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient bimatoprost (S01EE03)…